GSK plans return of HQ to central London in 2024
GSK on Monday said it was moving its global headquarters back to central London in 2024.
FTSE 100
8,053.00
11:10 14/11/24
FTSE 350
4,447.33
11:10 14/11/24
FTSE All-Share
4,405.01
11:10 14/11/24
GSK
1,356.50p
11:10 14/11/24
Pharmaceuticals & Biotechnology
19,680.11
11:10 14/11/24
The company will relocate from its current base in Brentford, West London - which it has occupied since 2002 - to new offices on New Oxford Street close to Tottenham Court Road.
It's new six storey building is under construction and due to be completed next year. Around 3000 people will work there on a hybrid basis including the GSK global leadership team headed by CEO Emma Walmsley.
GSK said the new HQ would allow it to be closer to London’s so called Knowledge Quarter and key partners such as the Francis Crick Institute and King’s College.
"The choice of central London offers easy access to GSK’s global R&D hub in Stevenage, as well as closer proximity to the company’s Artificial Intelligence and Machine Learning Hub in King’s Cross," it added.
Reporting by Frank Prenesti for Sharecast.com